The Evaluation Value of CT in the Efficacy of Neoadjuvant Chemotherapy in Ovarian Cancer Patients.
Journal
Contrast media & molecular imaging
ISSN: 1555-4317
Titre abrégé: Contrast Media Mol Imaging
Pays: England
ID NLM: 101286760
Informations de publication
Date de publication:
2022
2022
Historique:
received:
21
04
2022
revised:
16
05
2022
accepted:
17
05
2022
entrez:
8
7
2022
pubmed:
9
7
2022
medline:
12
7
2022
Statut:
epublish
Résumé
To discuss the evaluation value of CT in the efficacy of neoadjuvant chemotherapy in patients with ovarian cancer. The clinical, pathological, and CT imaging information of 72 patients with ovarian cancer treated in our hospital from January 2018 to January 2022 were retrospectively analyzed. CT examination and pathological examination were compared to evaluate the efficacy of neoadjuvant chemotherapy. Using the CRS grading system, 26 cases (36.11%) scored 1, 42 cases (58.33%) scored 2, and 4 cases (5.56%) scored 3. CRS grading system scores of 1, 2, 3, and 4-7 patients were compared, CT could be used to evaluate the efficacy of neoadjuvant chemotherapy for ovarian cancer.
Identifiants
pubmed: 35800240
doi: 10.1155/2022/7195888
pmc: PMC9200539
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
7195888Informations de copyright
Copyright © 2022 Daying Mou et al.
Déclaration de conflit d'intérêts
The authors declare that there are no conflicts of interest.
Références
Cancer Biol Ther. 2019;20(7):956-966
pubmed: 31062668
Sci Rep. 2021 Apr 28;11(1):9149
pubmed: 33911091
Am Fam Physician. 2016 Jun 1;93(11):937-44
pubmed: 27281838
N Engl J Med. 2010 Sep 2;363(10):943-53
pubmed: 20818904
CA Cancer J Clin. 2022 Jan;72(1):7-33
pubmed: 35020204
Int J Mol Sci. 2021 Jun 18;22(12):
pubmed: 34207103
Front Oncol. 2021 Nov 16;11:718815
pubmed: 34868915
Cureus. 2021 Dec 7;13(12):e20254
pubmed: 35004063
CA Cancer J Clin. 2019 Jul;69(4):280-304
pubmed: 31099893
Cancer Res Treat. 2020 Oct;52(4):1211-1218
pubmed: 32599990
Cancers (Basel). 2021 Feb 09;13(4):
pubmed: 33572451
Front Oncol. 2021 Apr 13;11:638124
pubmed: 33928029
Drug Discov Today. 2020 Jul;25(7):1232-1238
pubmed: 32360532
Am Soc Clin Oncol Educ Book. 2018 May 23;38:1019-1029
pubmed: 30231378
Am J Surg Pathol. 2020 Feb;44(2):206-213
pubmed: 31651523
J Thorac Oncol. 2018 Jul;13(7):1012-1021
pubmed: 29753121
Diagnostics (Basel). 2021 Dec 14;11(12):
pubmed: 34943597
Eur Radiol. 2020 Aug;30(8):4306-4316
pubmed: 32253542
Eur J Nucl Med Mol Imaging. 2021 Jun;48(6):1998-2008
pubmed: 33221969
Front Immunol. 2020 Oct 06;11:577869
pubmed: 33123161
Gastroenterol Res Pract. 2021 Apr 23;2021:5563136
pubmed: 33981339
Nat Commun. 2020 Dec 8;11(1):6298
pubmed: 33293516
Int J Mol Sci. 2019 Feb 22;20(4):
pubmed: 30813239
Korean J Radiol. 2021 Sep;22(9):1481-1489
pubmed: 34132077
J Ovarian Res. 2021 Nov 1;14(1):148
pubmed: 34724958
J Ovarian Res. 2018 Mar 2;11(1):20
pubmed: 29499737